{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:08:26Z","timestamp":1784610506847,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"vor","delay-in-days":50,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.nefroe.2023.10.004","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T14:54:27Z","timestamp":1698677667000},"page":"562-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epidemiology and treatment of renal anaemia in Spain: RIKAS retrospective study"],"prefix":"10.1016","volume":"43","author":[{"given":"Aleix","family":"Cases","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Gonz\u00e1lez de Antona","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Cadeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Mata","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2023.10.004_bib0005","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.nefroe.2023.10.004_bib0010","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2023.10.004_bib0015","article-title":"Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents","volume":"8","author":"Portol\u00e9s","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.nefroe.2023.10.004_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/gfg458","article-title":"Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2023.10.004_bib0025","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1185\/030079906X132541","article-title":"Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa","volume":"22","author":"Lefebvre","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.nefroe.2023.10.004_bib0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1440-1797.2008.01065.x","article-title":"Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease","volume":"14","author":"Thorp","year":"2009","journal-title":"Nephrology (Carlton)."},{"key":"10.1016\/j.nefroe.2023.10.004_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7692376","article-title":"The impact of CKD anaemia on patients: incidence, risk factors, and clinical outcomes-a systematic literature review","volume":"2020","author":"Palaka","year":"2020","journal-title":"Int J Nephrol."},{"issue":"7","key":"10.1016\/j.nefroe.2023.10.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease - A systematic review and meta-analysis.","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"issue":"10225","key":"10.1016\/j.nefroe.2023.10.004_bib0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.nefroe.2023.10.004_bib0050","first-page":"78","article-title":"Prevalence of chronic renal disease in Spain: results of the EPIRCE study","volume":"30","author":"Otero","year":"2010","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2023.10.004_bib0055","first-page":"223","article-title":"Strategy to estimate risk progression of chronic kidney disease, cardiovascular risk, and referral to nephrology: the EPIRCE Study","volume":"33","author":"Gayoso-Diaz","year":"2013","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2023.10.004_bib0060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nefro.2018.04.004","article-title":"Chronic kidney disease in Spain: prevalence and impact of accumulation of cardiovascular risk factors","volume":"38","author":"Gorostidi","year":"2018","journal-title":"Nefrologia."},{"issue":"10","key":"10.1016\/j.nefroe.2023.10.004_bib0065","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/08860220903216063","article-title":"Anemia development and cardiovascular risk management in nonanemic stage 3 chronic kidney disease","volume":"31","author":"Portol\u00e9s","year":"2009","journal-title":"Ren Fail"},{"key":"10.1016\/j.nefroe.2023.10.004_bib0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2369-12-53","article-title":"Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study","volume":"12","author":"Mart\u00ednez-Castelao","year":"2011","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2023.10.004_bib0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2369-14-2","article-title":"The development of anemia is associated to poor prognosis in NKF\/KDOQI stage 3 chronic kidney disease","volume":"14","author":"Portol\u00e9s","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2023.10.004_bib0080","first-page":"189","article-title":"Prevalence of anaemia and its clinical management in patients with stages 3-5 chronic kidney disease not on dialysis in Catalonia: MICENAS I study","volume":"34","author":"Cases-Amen\u00f3s","year":"2014","journal-title":"Nefrologia"},{"issue":"Suppl 1","key":"10.1016\/j.nefroe.2023.10.004_bib0085","first-page":"S36","article-title":"Analyzing kidney impairment in the elderly","volume":"8","author":"Guerrero","year":"2017","journal-title":"Eur Geriatr Med."},{"key":"10.1016\/j.nefroe.2023.10.004_bib0090","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1681\/ASN.2019020213","article-title":"Iron deficiency in chronic kidney disease: updates on pathophysiology, diagnosis, and treatment","volume":"31","author":"Batchelor","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2023.10.004_bib0095","unstructured":"European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Big-Pacdatabase, http:\/\/www.encepp.eu\/encepp\/search.htm; 2021 [accessed 16 Feb 2021]."},{"issue":"supl 3","key":"10.1016\/j.nefroe.2023.10.004_bib0100","article-title":"PMU146 Validation and representativeness of the Spanish Big-Pac database: integrated computerized medical records for research into epidemiology, medicines and health resource use (Real world evidence)","volume":"22","author":"Sicras-Mainar","year":"2019","journal-title":"Value in Health"},{"issue":"1","key":"10.1016\/j.nefroe.2023.10.004_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084943","article-title":"Prevalence of anemia in chronic kidney disease in the United States","volume":"9","author":"Stauffer","year":"2014","journal-title":"PLoS One."},{"issue":"5","key":"10.1016\/j.nefroe.2023.10.004_bib0110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/ckj\/sfaa054","article-title":"Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis","volume":"13","author":"Evans","year":"2020","journal-title":"Clin Kidney J."},{"issue":"3","key":"10.1016\/j.nefroe.2023.10.004_bib0115","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/ijms21030725","article-title":"The influence of inflammation on anemia in CKD patients","volume":"21","author":"Gluba-Brz\u00f3zka","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"2","key":"10.1016\/j.nefroe.2023.10.004_bib0120","first-page":"279","article-title":"KDIGO 2012 clinical practice guideline for anemia in chronic kidney disease","author":"Kidney Disease: Improving Global Outcomes (KDIGO)","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1016\/j.nefroe.2023.10.004_bib0125","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ndt\/gfn653","article-title":"Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP)","volume":"24","author":"Locatelli","year":"2009","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"10.1016\/j.nefroe.2023.10.004_bib0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nefroe.2018.01.007","article-title":"Anemia en la enfermedad renal cr\u00f3nica: protocolo de estudio, manejo y derivaci\u00f3n a Nefrolog\u00eda [Anemia of chronic kidney disease: protocol of study, management and referral to Nephrology]","volume":"38","author":"Cases","year":"2018","journal-title":"Nefrologia (Engl Ed)"},{"issue":"6","key":"10.1016\/j.nefroe.2023.10.004_bib0135","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European renal best practice position statement","volume":"28","author":"Locatelli","year":"2013","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2023.10.004_bib0140","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.ajkd.2015.11.012","article-title":"Diagnosis and management of iron deficiency in CKD: a summary of the NICE guideline recommendations and their rationale","volume":"67","author":"Ratcliffe","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.nefroe.2023.10.004_bib0145","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2016.04.018","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: an updated systematic review and meta-analysis","volume":"68","author":"Shepshelovich","year":"2016","journal-title":"Am J Kidney Dis."},{"issue":"111","key":"10.1016\/j.nefroe.2023.10.004_bib0150","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1038\/ki.2008.524","article-title":"Maintenance of target hemoglobin level in stable hemodialysis patients constitutes a theoretical task: a historical prospective study","author":"Portol\u00e9s","year":"2008","journal-title":"Kidney Int Suppl."}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251423001621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251423001621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:51:09Z","timestamp":1761853869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251423001621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2013251423001621"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2023.10.004","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and treatment of renal anaemia in Spain: RIKAS retrospective study","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2023.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2022.04.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}